At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines.
We are committed to operating in a way that recognises the interconnection between business growth, the needs of society and the limitations of our planet. Our sustainability priorities in Access to healthcare, Environmental protection, and Ethics and transparency support the delivery of our business strategy.
How do we approach sustainability at AstraZeneca?
Sustainability at AstraZeneca is about using our capabilities to make the most meaningful impact where society needs it — health. We work to integrate sustainability into every aspect of our enterprise to help future-proof our business to be resilient in challenging times, helping ensure we can continue to deliver life-changing medicines to patients.
Our sustainability strategy is guided by a materiality assessment. This process determines the topics that are most important to AstraZeneca and our stakeholders, giving us the opportunity to achieve the most positive impact. We have 16 material focus areas, which are grouped under three interconnected priorities — Access to healthcare, Environmental protection and Ethics and transparency.
Our three sustainability priorities
Access to healthcare
healthcare workers trained through our access programmes (cumulative)1
people reached through our access programmes (cumulative)1
people reached through our patient assistance programmes (cumulative)
reduction in our scope 1 and 2 greenhouse gas emissions since 2015
Ranked on the CDP A list for Climate Change and Water Security for the fifth consecutive year
reduction in our water use since 2015
Ethics & transparency
of senior middle management roles and above are held by women
of employee survey respondents feel that AstraZeneca is a Great Place to Work
countries launched new supplier diversity programmes
Access to healthcare, environmental protection and ethics & transparency priority areas continue to underpin our global Sustainability strategy, in full alignment with our business priorities. We made great progress in 2020, launching our Ambition Zero Carbon programme which accelerates our contribution to tackling the climate crisis in support of global health. Collaborating around the world, our commitment to transparency ensures that we are a trusted partner to increase access to innovative medicines and address the global health concerns of today and tomorrow.
1. Includes four access to healthcare programmes: Healthy Heart Africa, Healthy Lung, Phakamisa and Young Health Programme